デフォルト表紙
市場調査レポート
商品コード
1091265

世界のA型肝炎・B型肝炎ワクチン接種市場:考察と予測 (2028年まで)

Global Hepatitis A and B Vaccination Market Insights, Forecast to 2028

出版日: | 発行: QYResearch | ページ情報: 英文 119 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
世界のA型肝炎・B型肝炎ワクチン接種市場:考察と予測 (2028年まで)
出版日: 2022年06月20日
発行: QYResearch
ページ情報: 英文 119 Pages
納期: 2~3営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、A型肝炎・B型肝炎ワクチン接種 (Hepatitis A and B Vaccination) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • A型肝炎・B型肝炎ワクチン接種の製品概要
  • 市場:タイプ別
    • 世界のA型肝炎・B型肝炎ワクチン接種の市場規模成長率:タイプ別, 2017 VS 2021 VS 2028
    • Hepatitis A Vaccination
    • Hepatitis B Vaccination
  • 市場:アプリケーション別
    • 世界のA型肝炎・B型肝炎ワクチン接種の市場規模成長率:アプリケーション別, 2017 VS 2021 VS 2028
    • Government Institution
    • Private Sector
    • Other
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界のA型肝炎・B型肝炎ワクチン接種の販売 推定および予測 2017-2028
  • 世界のA型肝炎・B型肝炎ワクチン接種の収益 推定および予測 2017-2028
  • 世界のA型肝炎・B型肝炎ワクチン接種の収益:地域別: 2017 VS 2021 VS 2028
  • 世界のA型肝炎・B型肝炎ワクチン接種の販売:地域別
    • 世界のA型肝炎・B型肝炎ワクチン接種の販売:地域別 (2017-2022)
    • 世界の販売 A型肝炎・B型肝炎ワクチン接種 :地域別 (2023-2028)
  • 世界のA型肝炎・B型肝炎ワクチン接種の収益:地域別
    • 世界のA型肝炎・B型肝炎ワクチン接種の収益:地域別 (2017-2022)
    • 世界のA型肝炎・B型肝炎ワクチン接種の収益:地域別 (2023-2028)
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第3章 競合:メーカー別

  • 世界のA型肝炎・B型肝炎ワクチン接種の販売:メーカー別
    • 世界のA型肝炎・B型肝炎ワクチン接種の上位メーカー:販売別 (2017-2022)
    • 世界のA型肝炎・B型肝炎ワクチン接種の販売市場シェア:メーカー別 (2017-2022)
    • 世界の上位10・上位5メーカー: A型肝炎・B型肝炎ワクチン接種2021
  • 世界のA型肝炎・B型肝炎ワクチン接種の収益:メーカー別
    • 世界のA型肝炎・B型肝炎ワクチン接種の収益:メーカー別 (2017-2022)
    • 世界のA型肝炎・B型肝炎ワクチン接種の収益市場シェア:メーカー別 (2017-2022)
    • 世界の上位10・上位5企業: A型肝炎・B型肝炎ワクチン接種の収益 2021
  • 世界のA型肝炎・B型肝炎ワクチン接種の販売価格:メーカー別 (2017-2022)
  • 競合情勢の分析
    • メーカーの市場集中度 (CR5 and HHI)
    • 世界のA型肝炎・B型肝炎ワクチン接種の市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
    • 世界のA型肝炎・B型肝炎ワクチン接種のメーカーの地理的分布
  • M&A, 拡張計画

第4章 市場規模:タイプ別

  • 世界のA型肝炎・B型肝炎ワクチン接種の販売:タイプ別
    • 世界のA型肝炎・B型肝炎ワクチン接種の販売実績:タイプ別 (2017-2022)
    • 世界のA型肝炎・B型肝炎ワクチン接種の販売予測:タイプ別 (2023-2028)
    • 世界のA型肝炎・B型肝炎ワクチン接種の販売市場シェア:タイプ別 (2017-2028)
  • 世界のA型肝炎・B型肝炎ワクチン接種の収益:タイプ別
    • 世界のA型肝炎・B型肝炎ワクチン接種の収益実績:タイプ別 (2017-2022)
    • 世界のA型肝炎・B型肝炎ワクチン接種の収益予測:タイプ別 (2023-2028)
    • 世界のA型肝炎・B型肝炎ワクチン接種の収益市場シェア:タイプ別 (2017-2028)
  • 世界のA型肝炎・B型肝炎ワクチン接種の価格:タイプ別
    • 世界のA型肝炎・B型肝炎ワクチン接種の価格:タイプ別 (2017-2022)
    • 世界のA型肝炎・B型肝炎ワクチン接種の価格予測:タイプ別 (2023-2028)

第5章 市場規模:アプリケーション別

  • 世界のA型肝炎・B型肝炎ワクチン接種の販売:アプリケーション別
    • 世界のA型肝炎・B型肝炎ワクチン接種の販売実績:アプリケーション別 (2017-2022)
    • 世界のA型肝炎・B型肝炎ワクチン接種の販売予測:アプリケーション別 (2023-2028)
    • 世界のA型肝炎・B型肝炎ワクチン接種の販売市場シェア:アプリケーション別 (2017-2028)
  • 世界のA型肝炎・B型肝炎ワクチン接種の収益:アプリケーション別
    • 世界のA型肝炎・B型肝炎ワクチン接種の収益実績:アプリケーション別 (2017-2022)
    • 世界のA型肝炎・B型肝炎ワクチン接種の収益予測:アプリケーション別 (2023-2028)
    • 世界のA型肝炎・B型肝炎ワクチン接種の収益市場シェア:アプリケーション別 (2017-2028)
  • 世界のA型肝炎・B型肝炎ワクチン接種の価格:アプリケーション別
    • 世界のA型肝炎・B型肝炎ワクチン接種の価格:アプリケーション別 (2017-2022)
    • 世界のA型肝炎・B型肝炎ワクチン接種の価格予測:アプリケーション別 (2023-2028)

第6章 北米

  • 北米のA型肝炎・B型肝炎ワクチン接種 市場規模:タイプ別
    • 北米のA型肝炎・B型肝炎ワクチン接種の販売:タイプ別 (2017-2028)
    • 北米のA型肝炎・B型肝炎ワクチン接種の収益:タイプ別 (2017-2028)
  • 北米のA型肝炎・B型肝炎ワクチン接種 市場規模:アプリケーション別
    • 北米のA型肝炎・B型肝炎ワクチン接種の販売:アプリケーション別 (2017-2028)
    • 北米のA型肝炎・B型肝炎ワクチン接種の収益:アプリケーション別 (2017-2028)
  • 北米のA型肝炎・B型肝炎ワクチン接種 市場規模:国別
    • 北米のA型肝炎・B型肝炎ワクチン接種の販売:国別 (2017-2028)
    • 北米のA型肝炎・B型肝炎ワクチン接種の収益:国別 (2017-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のA型肝炎・B型肝炎ワクチン接種 市場規模:タイプ別
    • 欧州のA型肝炎・B型肝炎ワクチン接種の販売:タイプ別 (2017-2028)
    • 欧州のA型肝炎・B型肝炎ワクチン接種の収益:タイプ別 (2017-2028)
  • 欧州のA型肝炎・B型肝炎ワクチン接種 市場規模:アプリケーション別
    • 欧州のA型肝炎・B型肝炎ワクチン接種の販売:アプリケーション別 (2017-2028)
    • 欧州のA型肝炎・B型肝炎ワクチン接種の収益:アプリケーション別 (2017-2028)
  • 欧州のA型肝炎・B型肝炎ワクチン接種 市場規模:国別
    • 欧州のA型肝炎・B型肝炎ワクチン接種の販売:国別 (2017-2028)
    • 欧州のA型肝炎・B型肝炎ワクチン接種の収益:国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • アジア太平洋のA型肝炎・B型肝炎ワクチン接種 市場規模:タイプ別
    • アジア太平洋のA型肝炎・B型肝炎ワクチン接種の販売:タイプ別 (2017-2028)
    • アジア太平洋のA型肝炎・B型肝炎ワクチン接種の収益:タイプ別 (2017-2028)
  • アジア太平洋のA型肝炎・B型肝炎ワクチン接種 市場規模:アプリケーション別
    • アジア太平洋のA型肝炎・B型肝炎ワクチン接種の販売:アプリケーション別 (2017-2028)
    • アジア太平洋のA型肝炎・B型肝炎ワクチン接種の収益:アプリケーション別 (2017-2028)
  • アジア太平洋のA型肝炎・B型肝炎ワクチン接種 市場規模:地域別
    • アジア太平洋のA型肝炎・B型肝炎ワクチン接種の販売:地域別 (2017-2028)
    • アジア太平洋のA型肝炎・B型肝炎ワクチン接種の収益:地域別 (2017-2028)
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 中国の台湾
    • インドネシア
    • タイ
    • マレーシア

第9章 ラテンアメリカ

  • ラテンアメリカのA型肝炎・B型肝炎ワクチン接種 市場規模:タイプ別
    • ラテンアメリカのA型肝炎・B型肝炎ワクチン接種の販売:タイプ別 (2017-2028)
    • ラテンアメリカのA型肝炎・B型肝炎ワクチン接種の収益:タイプ別 (2017-2028)
  • ラテンアメリカのA型肝炎・B型肝炎ワクチン接種 市場規模:アプリケーション別
    • ラテンアメリカのA型肝炎・B型肝炎ワクチン接種の販売:アプリケーション別 (2017-2028)
    • ラテンアメリカのA型肝炎・B型肝炎ワクチン接種の収益:アプリケーション別 (2017-2028)
  • ラテンアメリカのA型肝炎・B型肝炎ワクチン接種 市場規模:国別
    • ラテンアメリカのA型肝炎・B型肝炎ワクチン接種の販売:国別 (2017-2028)
    • ラテンアメリカのA型肝炎・B型肝炎ワクチン接種の収益:国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン

第10章 中東・アフリカ

  • 中東・アフリカのA型肝炎・B型肝炎ワクチン接種 市場規模:タイプ別
    • 中東・アフリカのA型肝炎・B型肝炎ワクチン接種の販売:タイプ別 (2017-2028)
    • 中東・アフリカのA型肝炎・B型肝炎ワクチン接種の収益:タイプ別 (2017-2028)
  • 中東・アフリカのA型肝炎・B型肝炎ワクチン接種 市場規模:アプリケーション別
    • 中東・アフリカのA型肝炎・B型肝炎ワクチン接種の販売:アプリケーション別 (2017-2028)
    • 中東・アフリカのA型肝炎・B型肝炎ワクチン接種の収益:アプリケーション別 (2017-2028)
  • 中東・アフリカのA型肝炎・B型肝炎ワクチン接種 市場規模:国別
    • 中東・アフリカのA型肝炎・B型肝炎ワクチン接種の販売:国別 (2017-2028)
    • 中東・アフリカのA型肝炎・B型肝炎ワクチン接種の収益:国別 (2017-2028)
    • トルコ
    • サウジアラビア

第11章 企業プロファイル

  • GSK
  • Merck
  • Sanofi
  • Sinovac
  • Zhejiang Pukang
  • Changchun Institute of Biological
  • KM Biologics
  • IMBCAMS
  • Convac
  • NCPC
  • Bio Kangtai
  • Dynavax
  • Hissen
  • LG Life Sciences
  • Serum Institute

第12章 業界チェーンと販売チャネルの分析

  • A型肝炎・B型肝炎ワクチン接種 業界チェーン分析
  • A型肝炎・B型肝炎ワクチン接種 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • A型肝炎・B型肝炎ワクチン接種 生産形態とプロセス
  • A型肝炎・B型肝炎ワクチン接種 販売およびマーケティング
    • A型肝炎・B型肝炎ワクチン接種 販売チャネル
    • A型肝炎・B型肝炎ワクチン接種 卸業者
  • A型肝炎・B型肝炎ワクチン接種 顧客

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

  • A型肝炎・B型肝炎ワクチン接種 業界動向
  • A型肝炎・B型肝炎ワクチン接種 市場の促進要因
  • A型肝炎・B型肝炎ワクチン接種 市場の課題
  • A型肝炎・B型肝炎ワクチン接種 市場の抑制要因

第14章 世界のA型肝炎・B型肝炎ワクチン接種の主な市場調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global Hepatitis A and B Vaccination Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Hepatitis A Vaccination
  • Table 3. Major Manufacturers of Hepatitis B Vaccination
  • Table 4. Global Hepatitis A and B Vaccination Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 5. Global Hepatitis A and B Vaccination Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 6. Global Hepatitis A and B Vaccination Sales by Region (2017-2022) & (Units)
  • Table 7. Global Hepatitis A and B Vaccination Sales Market Share by Region (2017-2022)
  • Table 8. Global Hepatitis A and B Vaccination Sales by Region (2023-2028) & (Units)
  • Table 9. Global Hepatitis A and B Vaccination Sales Market Share by Region (2023-2028)
  • Table 10. Global Hepatitis A and B Vaccination Revenue by Region (2017-2022) & (US$ Million)
  • Table 11. Global Hepatitis A and B Vaccination Revenue Market Share by Region (2017-2022)
  • Table 12. Global Hepatitis A and B Vaccination Revenue by Region (2023-2028) & (US$ Million)
  • Table 13. Global Hepatitis A and B Vaccination Revenue Market Share by Region (2023-2028)
  • Table 14. Global Hepatitis A and B Vaccination Sales by Manufacturers (2017-2022) & (Units)
  • Table 15. Global Hepatitis A and B Vaccination Sales Share by Manufacturers (2017-2022)
  • Table 16. Global Hepatitis A and B Vaccination Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 17. Global Hepatitis A and B Vaccination Revenue Share by Manufacturers (2017-2022)
  • Table 18. Hepatitis A and B Vaccination Price by Manufacturers (2017-2022) &(US$/Unit)
  • Table 19. Global Hepatitis A and B Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 20. Global Hepatitis A and B Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A and B Vaccination as of 2021)
  • Table 21. Hepatitis A and B Vaccination Manufacturing Base Distribution and Headquarters
  • Table 22. Manufacturers Hepatitis A and B Vaccination Product Offered
  • Table 23. Date of Manufacturers Enter into Hepatitis A and B Vaccination Market
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Hepatitis A and B Vaccination Sales by Type (2017-2022) & (Units)
  • Table 26. Global Hepatitis A and B Vaccination Sales by Type (2023-2028) & (Units)
  • Table 27. Global Hepatitis A and B Vaccination Sales Share by Type (2017-2022)
  • Table 28. Global Hepatitis A and B Vaccination Sales Share by Type (2023-2028)
  • Table 29. Global Hepatitis A and B Vaccination Revenue by Type (2017-2022) & (US$ Million)
  • Table 30. Global Hepatitis A and B Vaccination Revenue by Type (2023-2028) & (US$ Million)
  • Table 31. Global Hepatitis A and B Vaccination Revenue Share by Type (2017-2022)
  • Table 32. Global Hepatitis A and B Vaccination Revenue Share by Type (2023-2028)
  • Table 33. Hepatitis A and B Vaccination Price by Type (2017-2022) & (US$/Unit)
  • Table 34. Global Hepatitis A and B Vaccination Price Forecast by Type (2023-2028) & (US$/Unit)
  • Table 35. Global Hepatitis A and B Vaccination Sales by Application (2017-2022) & (Units)
  • Table 36. Global Hepatitis A and B Vaccination Sales by Application (2023-2028) & (Units)
  • Table 37. Global Hepatitis A and B Vaccination Sales Share by Application (2017-2022)
  • Table 38. Global Hepatitis A and B Vaccination Sales Share by Application (2023-2028)
  • Table 39. Global Hepatitis A and B Vaccination Revenue by Application (2017-2022) & (US$ Million)
  • Table 40. Global Hepatitis A and B Vaccination Revenue by Application (2023-2028) & (US$ Million)
  • Table 41. Global Hepatitis A and B Vaccination Revenue Share by Application (2017-2022)
  • Table 42. Global Hepatitis A and B Vaccination Revenue Share by Application (2023-2028)
  • Table 43. Hepatitis A and B Vaccination Price by Application (2017-2022) & (US$/Unit)
  • Table 44. Global Hepatitis A and B Vaccination Price Forecast by Application (2023-2028) & (US$/Unit)
  • Table 45. North America Hepatitis A and B Vaccination Sales by Type (2017-2022) & (Units)
  • Table 46. North America Hepatitis A and B Vaccination Sales by Type (2023-2028) & (Units)
  • Table 47. North America Hepatitis A and B Vaccination Revenue by Type (2017-2022) & (US$ Million)
  • Table 48. North America Hepatitis A and B Vaccination Revenue by Type (2023-2028) & (US$ Million)
  • Table 49. North America Hepatitis A and B Vaccination Sales by Application (2017-2022) & (Units)
  • Table 50. North America Hepatitis A and B Vaccination Sales by Application (2023-2028) & (Units)
  • Table 51. North America Hepatitis A and B Vaccination Revenue by Application (2017-2022) & (US$ Million)
  • Table 52. North America Hepatitis A and B Vaccination Revenue by Application (2023-2028) & (US$ Million)
  • Table 53. North America Hepatitis A and B Vaccination Sales by Country (2017-2022) & (Units)
  • Table 54. North America Hepatitis A and B Vaccination Sales by Country (2023-2028) & (Units)
  • Table 55. North America Hepatitis A and B Vaccination Revenue by Country (2017-2022) & (US$ Million)
  • Table 56. North America Hepatitis A and B Vaccination Revenue by Country (2023-2028) & (US$ Million)
  • Table 57. Europe Hepatitis A and B Vaccination Sales by Type (2017-2022) & (Units)
  • Table 58. Europe Hepatitis A and B Vaccination Sales by Type (2023-2028) & (Units)
  • Table 59. Europe Hepatitis A and B Vaccination Revenue by Type (2017-2022) & (US$ Million)
  • Table 60. Europe Hepatitis A and B Vaccination Revenue by Type (2023-2028) & (US$ Million)
  • Table 61. Europe Hepatitis A and B Vaccination Sales by Application (2017-2022) & (Units)
  • Table 62. Europe Hepatitis A and B Vaccination Sales by Application (2023-2028) & (Units)
  • Table 63. Europe Hepatitis A and B Vaccination Revenue by Application (2017-2022) & (US$ Million)
  • Table 64. Europe Hepatitis A and B Vaccination Revenue by Application (2023-2028) & (US$ Million)
  • Table 65. Europe Hepatitis A and B Vaccination Sales by Country (2017-2022) & (Units)
  • Table 66. Europe Hepatitis A and B Vaccination Sales by Country (2023-2028) & (Units)
  • Table 67. Europe Hepatitis A and B Vaccination Revenue by Country (2017-2022) & (US$ Million)
  • Table 68. Europe Hepatitis A and B Vaccination Revenue by Country (2023-2028) & (US$ Million)
  • Table 69. Asia Pacific Hepatitis A and B Vaccination Sales by Type (2017-2022) & (Units)
  • Table 70. Asia Pacific Hepatitis A and B Vaccination Sales by Type (2023-2028) & (Units)
  • Table 71. Asia Pacific Hepatitis A and B Vaccination Revenue by Type (2017-2022) & (US$ Million)
  • Table 72. Asia Pacific Hepatitis A and B Vaccination Revenue by Type (2023-2028) & (US$ Million)
  • Table 73. Asia Pacific Hepatitis A and B Vaccination Sales by Application (2017-2022) & (Units)
  • Table 74. Asia Pacific Hepatitis A and B Vaccination Sales by Application (2023-2028) & (Units)
  • Table 75. Asia Pacific Hepatitis A and B Vaccination Revenue by Application (2017-2022) & (US$ Million)
  • Table 76. Asia Pacific Hepatitis A and B Vaccination Revenue by Application (2023-2028) & (US$ Million)
  • Table 77. Asia Pacific Hepatitis A and B Vaccination Sales by Region (2017-2022) & (Units)
  • Table 78. Asia Pacific Hepatitis A and B Vaccination Sales by Region (2023-2028) & (Units)
  • Table 79. Asia Pacific Hepatitis A and B Vaccination Revenue by Region (2017-2022) & (US$ Million)
  • Table 80. Asia Pacific Hepatitis A and B Vaccination Revenue by Region (2023-2028) & (US$ Million)
  • Table 81. Latin America Hepatitis A and B Vaccination Sales by Type (2017-2022) & (Units)
  • Table 82. Latin America Hepatitis A and B Vaccination Sales by Type (2023-2028) & (Units)
  • Table 83. Latin America Hepatitis A and B Vaccination Revenue by Type (2017-2022) & (US$ Million)
  • Table 84. Latin America Hepatitis A and B Vaccination Revenue by Type (2023-2028) & (US$ Million)
  • Table 85. Latin America Hepatitis A and B Vaccination Sales by Application (2017-2022) & (Units)
  • Table 86. Latin America Hepatitis A and B Vaccination Sales by Application (2023-2028) & (Units)
  • Table 87. Latin America Hepatitis A and B Vaccination Revenue by Application (2017-2022) & (US$ Million)
  • Table 88. Latin America Hepatitis A and B Vaccination Revenue by Application (2023-2028) & (US$ Million)
  • Table 89. Latin America Hepatitis A and B Vaccination Sales by Country (2017-2022) & (Units)
  • Table 90. Latin America Hepatitis A and B Vaccination Sales by Country (2023-2028) & (Units)
  • Table 91. Latin America Hepatitis A and B Vaccination Revenue by Country (2017-2022) & (US$ Million)
  • Table 92. Latin America Hepatitis A and B Vaccination Revenue by Country (2023-2028) & (US$ Million)
  • Table 93. Middle East and Africa Hepatitis A and B Vaccination Sales by Type (2017-2022) & (Units)
  • Table 94. Middle East and Africa Hepatitis A and B Vaccination Sales by Type (2023-2028) & (Units)
  • Table 95. Middle East and Africa Hepatitis A and B Vaccination Revenue by Type (2017-2022) & (US$ Million)
  • Table 96. Middle East and Africa Hepatitis A and B Vaccination Revenue by Type (2023-2028) & (US$ Million)
  • Table 97. Middle East and Africa Hepatitis A and B Vaccination Sales by Application (2017-2022) & (Units)
  • Table 98. Middle East and Africa Hepatitis A and B Vaccination Sales by Application (2023-2028) & (Units)
  • Table 99. Middle East and Africa Hepatitis A and B Vaccination Revenue by Application (2017-2022) & (US$ Million)
  • Table 100. Middle East and Africa Hepatitis A and B Vaccination Revenue by Application (2023-2028) & (US$ Million)
  • Table 101. Middle East and Africa Hepatitis A and B Vaccination Sales by Country (2017-2022) & (Units)
  • Table 102. Middle East and Africa Hepatitis A and B Vaccination Sales by Country (2023-2028) & (Units)
  • Table 103. Middle East and Africa Hepatitis A and B Vaccination Revenue by Country (2017-2022) & (US$ Million)
  • Table 104. Middle East and Africa Hepatitis A and B Vaccination Revenue by Country (2023-2028) & (US$ Million)
  • Table 105. GSK Corporation Information
  • Table 106. GSK Description and Major Businesses
  • Table 107. GSK Hepatitis A and B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 108. GSK Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 109. GSK Recent Developments
  • Table 110. Merck Corporation Information
  • Table 111. Merck Description and Major Businesses
  • Table 112. Merck Hepatitis A and B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 113. Merck Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 114. Merck Recent Developments
  • Table 115. Sanofi Corporation Information
  • Table 116. Sanofi Description and Major Businesses
  • Table 117. Sanofi Hepatitis A and B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 118. Sanofi Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 119. Sanofi Recent Developments
  • Table 120. Sinovac Corporation Information
  • Table 121. Sinovac Description and Major Businesses
  • Table 122. Sinovac Hepatitis A and B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 123. Sinovac Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 124. Sinovac Recent Developments
  • Table 125. Zhejiang Pukang Corporation Information
  • Table 126. Zhejiang Pukang Description and Major Businesses
  • Table 127. Zhejiang Pukang Hepatitis A and B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 128. Zhejiang Pukang Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 129. Zhejiang Pukang Recent Developments
  • Table 130. Changchun Institute of Biological Corporation Information
  • Table 131. Changchun Institute of Biological Description and Major Businesses
  • Table 132. Changchun Institute of Biological Hepatitis A and B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 133. Changchun Institute of Biological Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 134. Changchun Institute of Biological Recent Developments
  • Table 135. KM Biologics Corporation Information
  • Table 136. KM Biologics Description and Major Businesses
  • Table 137. KM Biologics Hepatitis A and B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 138. KM Biologics Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 139. KM Biologics Recent Developments
  • Table 140. IMBCAMS Corporation Information
  • Table 141. IMBCAMS Description and Major Businesses
  • Table 142. IMBCAMS Hepatitis A and B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 143. IMBCAMS Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 144. IMBCAMS Recent Developments
  • Table 145. Convac Corporation Information
  • Table 146. Convac Description and Major Businesses
  • Table 147. Convac Hepatitis A and B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 148. Convac Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 149. Convac Recent Developments
  • Table 150. NCPC Corporation Information
  • Table 151. NCPC Description and Major Businesses
  • Table 152. NCPC Hepatitis A and B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 153. NCPC Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 154. NCPC Recent Developments
  • Table 155. Bio Kangtai Corporation Information
  • Table 156. Bio Kangtai Description and Major Businesses
  • Table 157. Bio Kangtai Hepatitis A and B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 158. Bio Kangtai Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 159. Bio Kangtai Recent Developments
  • Table 160. Dynavax Corporation Information
  • Table 161. Dynavax Description and Major Businesses
  • Table 162. Dynavax Hepatitis A and B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 163. Dynavax Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 164. Dynavax Recent Developments
  • Table 165. Hissen Corporation Information
  • Table 166. Hissen Description and Major Businesses
  • Table 167. Hissen Hepatitis A and B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 168. Hissen Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 169. Hissen Recent Developments
  • Table 170. LG Life Sciences Corporation Information
  • Table 171. LG Life Sciences Description and Major Businesses
  • Table 172. LG Life Sciences Hepatitis A and B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 173. LG Life Sciences Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 174. LG Life Sciences Recent Developments
  • Table 175. Serum Institute Corporation Information
  • Table 176. Serum Institute Description and Major Businesses
  • Table 177. Serum Institute Hepatitis A and B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 178. Serum Institute Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 179. Serum Institute Recent Developments
  • Table 180. Key Raw Materials Lists
  • Table 181. Raw Materials Key Suppliers Lists
  • Table 182. Hepatitis A and B Vaccination Distributors List
  • Table 183. Hepatitis A and B Vaccination Customers List
  • Table 184. Hepatitis A and B Vaccination Market Trends
  • Table 185. Hepatitis A and B Vaccination Market Drivers
  • Table 186. Hepatitis A and B Vaccination Market Challenges
  • Table 187. Hepatitis A and B Vaccination Market Restraints
  • Table 188. Research Programs/Design for This Report
  • Table 189. Key Data Information from Secondary Sources
  • Table 190. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Hepatitis A and B Vaccination Product Picture
  • Figure 3. Global Hepatitis A and B Vaccination Market Share by Type in 2021 & 2028
  • Figure 3. Hepatitis A Vaccination Product Picture
  • Figure 4. Hepatitis B Vaccination Product Picture
  • Figure 5. Global Hepatitis A and B Vaccination Market Share by Application in 2021 & 2028
  • Figure 6. Government Institution
  • Figure 7. Private Sector
  • Figure 8. Other
  • Figure 9. Hepatitis A and B Vaccination Report Years Considered
  • Figure 10. Global Hepatitis A and B Vaccination Sales 2017-2028 (Units)
  • Figure 11. Global Hepatitis A and B Vaccination Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 12. Global Hepatitis A and B Vaccination Revenue 2017-2028 (US$ Million)
  • Figure 13. Global Hepatitis A and B Vaccination Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 14. Global Hepatitis A and B Vaccination Sales Market Share by Region (2017-2022)
  • Figure 15. Global Hepatitis A and B Vaccination Sales Market Share by Region (2023-2028)
  • Figure 16. North America Hepatitis A and B Vaccination Sales YoY (2017-2028) & (Units)
  • Figure 17. North America Hepatitis A and B Vaccination Revenue YoY (2017-2028) & (US$ Million)
  • Figure 18. Europe Hepatitis A and B Vaccination Sales YoY (2017-2028) & (Units)
  • Figure 19. Europe Hepatitis A and B Vaccination Revenue YoY (2017-2028) & (US$ Million)
  • Figure 20. Asia-Pacific Hepatitis A and B Vaccination Sales YoY (2017-2028) & (Units)
  • Figure 21. Asia-Pacific Hepatitis A and B Vaccination Revenue YoY (2017-2028) & (US$ Million)
  • Figure 22. Latin America Hepatitis A and B Vaccination Sales YoY (2017-2028) & (Units)
  • Figure 23. Latin America Hepatitis A and B Vaccination Revenue YoY (2017-2028) & (US$ Million)
  • Figure 24. Middle East & Africa Hepatitis A and B Vaccination Sales YoY (2017-2028) & (Units)
  • Figure 25. Middle East & Africa Hepatitis A and B Vaccination Revenue YoY (2017-2028) & (US$ Million)
  • Figure 26. The Hepatitis A and B Vaccination Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 27. The Top 5 and 10 Largest Manufacturers of Hepatitis A and B Vaccination in the World: Market Share by Hepatitis A and B Vaccination Revenue in 2021
  • Figure 28. Global Hepatitis A and B Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 29. Global Hepatitis A and B Vaccination Sales Market Share by Type (2017-2028)
  • Figure 30. Global Hepatitis A and B Vaccination Revenue Market Share by Type (2017-2028)
  • Figure 31. Global Hepatitis A and B Vaccination Sales Market Share by Application (2017-2028)
  • Figure 32. Global Hepatitis A and B Vaccination Revenue Market Share by Application (2017-2028)
  • Figure 33. North America Hepatitis A and B Vaccination Sales Market Share by Type (2017-2028)
  • Figure 34. North America Hepatitis A and B Vaccination Revenue Market Share by Type (2017-2028)
  • Figure 35. North America Hepatitis A and B Vaccination Sales Market Share by Application (2017-2028)
  • Figure 36. North America Hepatitis A and B Vaccination Revenue Market Share by Application (2017-2028)
  • Figure 37. North America Hepatitis A and B Vaccination Sales Share by Country (2017-2028)
  • Figure 38. North America Hepatitis A and B Vaccination Revenue Share by Country (2017-2028)
  • Figure 39. United States Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 40. Canada Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 41. Europe Hepatitis A and B Vaccination Sales Market Share by Type (2017-2028)
  • Figure 42. Europe Hepatitis A and B Vaccination Revenue Market Share by Type (2017-2028)
  • Figure 43. Europe Hepatitis A and B Vaccination Sales Market Share by Application (2017-2028)
  • Figure 44. Europe Hepatitis A and B Vaccination Revenue Market Share by Application (2017-2028)
  • Figure 45. Europe Hepatitis A and B Vaccination Sales Share by Country (2017-2028)
  • Figure 46. Europe Hepatitis A and B Vaccination Revenue Share by Country (2017-2028)
  • Figure 47. Germany Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 48. France Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 49. U.K. Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 50. Italy Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 51. Russia Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 52. Asia Pacific Hepatitis A and B Vaccination Sales Market Share by Type (2017-2028)
  • Figure 53. Asia Pacific Hepatitis A and B Vaccination Revenue Market Share by Type (2017-2028)
  • Figure 54. Asia Pacific Hepatitis A and B Vaccination Sales Market Share by Application (2017-2028)
  • Figure 55. Asia Pacific Hepatitis A and B Vaccination Revenue Market Share by Application (2017-2028)
  • Figure 56. Asia Pacific Hepatitis A and B Vaccination Sales Share by Region (2017-2028)
  • Figure 57. Asia Pacific Hepatitis A and B Vaccination Revenue Share by Region (2017-2028)
  • Figure 58. China Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 59. Japan Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 60. South Korea Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 61. India Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 62. Australia Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 63. China Taiwan Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 64. Indonesia Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 65. Thailand Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 66. Malaysia Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 67. Latin America Hepatitis A and B Vaccination Sales Market Share by Type (2017-2028)
  • Figure 68. Latin America Hepatitis A and B Vaccination Revenue Market Share by Type (2017-2028)
  • Figure 69. Latin America Hepatitis A and B Vaccination Sales Market Share by Application (2017-2028)
  • Figure 70. Latin America Hepatitis A and B Vaccination Revenue Market Share by Application (2017-2028)
  • Figure 71. Latin America Hepatitis A and B Vaccination Sales Share by Country (2017-2028)
  • Figure 72. Latin America Hepatitis A and B Vaccination Revenue Share by Country (2017-2028)
  • Figure 73. Mexico Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 74. Brazil Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 75. Argentina Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 76. Middle East and Africa Hepatitis A and B Vaccination Sales Market Share by Type (2017-2028)
  • Figure 77. Middle East and Africa Hepatitis A and B Vaccination Revenue Market Share by Type (2017-2028)
  • Figure 78. Middle East and Africa Hepatitis A and B Vaccination Sales Market Share by Application (2017-2028)
  • Figure 79. Middle East and Africa Hepatitis A and B Vaccination Revenue Market Share by Application (2017-2028)
  • Figure 80. Middle East and Africa Hepatitis A and B Vaccination Sales Share by Country (2017-2028)
  • Figure 81. Middle East and Africa Hepatitis A and B Vaccination Revenue Share by Country (2017-2028)
  • Figure 82. Turkey Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 83. Saudi Arabia Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 84. UAE Hepatitis A and B Vaccination Revenue (2017-2028) & (US$ Million)
  • Figure 85. Hepatitis A and B Vaccination Value Chain
  • Figure 86. Hepatitis A and B Vaccination Production Process
  • Figure 87. Channels of Distribution
  • Figure 88. Distributors Profiles
  • Figure 89. Bottom-up and Top-down Approaches for This Report
  • Figure 90. Data Triangulation
  • Figure 91. Key Executives Interviewed
目次

This research report focuses on the Hepatitis A and B Vaccination Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Hepatitis A and B Vaccination Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Hepatitis A and B Vaccination Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Hepatitis A Vaccination
    • 1.2.3 Hepatitis B Vaccination
  • 1.3 Market by Application
    • 1.3.1 Global Hepatitis A and B Vaccination Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Government Institution
    • 1.3.3 Private Sector
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Hepatitis A and B Vaccination Sales Estimates and Forecasts 2017-2028
  • 2.2 Global Hepatitis A and B Vaccination Revenue Estimates and Forecasts 2017-2028
  • 2.3 Global Hepatitis A and B Vaccination Revenue by Region: 2017 VS 2021 VS 2028
  • 2.4 Global Hepatitis A and B Vaccination Sales by Region
    • 2.4.1 Global Hepatitis A and B Vaccination Sales by Region (2017-2022)
    • 2.4.2 Global Sales Hepatitis A and B Vaccination by Region (2023-2028)
  • 2.5 Global Hepatitis A and B Vaccination Revenue by Region
    • 2.5.1 Global Hepatitis A and B Vaccination Revenue by Region (2017-2022)
    • 2.5.2 Global Hepatitis A and B Vaccination Revenue by Region (2023-2028)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Hepatitis A and B Vaccination Sales by Manufacturers
    • 3.1.1 Global Top Hepatitis A and B Vaccination Manufacturers by Sales (2017-2022)
    • 3.1.2 Global Hepatitis A and B Vaccination Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatitis A and B Vaccination in 2021
  • 3.2 Global Hepatitis A and B Vaccination Revenue by Manufacturers
    • 3.2.1 Global Hepatitis A and B Vaccination Revenue by Manufacturers (2017-2022)
    • 3.2.2 Global Hepatitis A and B Vaccination Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Global Top 10 and Top 5 Companies by Hepatitis A and B Vaccination Revenue in 2021
  • 3.3 Global Hepatitis A and B Vaccination Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Hepatitis A and B Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Hepatitis A and B Vaccination Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Hepatitis A and B Vaccination Sales by Type
    • 4.1.1 Global Hepatitis A and B Vaccination Historical Sales by Type (2017-2022)
    • 4.1.2 Global Hepatitis A and B Vaccination Forecasted Sales by Type (2023-2028)
    • 4.1.3 Global Hepatitis A and B Vaccination Sales Market Share by Type (2017-2028)
  • 4.2 Global Hepatitis A and B Vaccination Revenue by Type
    • 4.2.1 Global Hepatitis A and B Vaccination Historical Revenue by Type (2017-2022)
    • 4.2.2 Global Hepatitis A and B Vaccination Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Global Hepatitis A and B Vaccination Revenue Market Share by Type (2017-2028)
  • 4.3 Global Hepatitis A and B Vaccination Price by Type
    • 4.3.1 Global Hepatitis A and B Vaccination Price by Type (2017-2022)
    • 4.3.2 Global Hepatitis A and B Vaccination Price Forecast by Type (2023-2028)

5 Market Size by Application

  • 5.1 Global Hepatitis A and B Vaccination Sales by Application
    • 5.1.1 Global Hepatitis A and B Vaccination Historical Sales by Application (2017-2022)
    • 5.1.2 Global Hepatitis A and B Vaccination Forecasted Sales by Application (2023-2028)
    • 5.1.3 Global Hepatitis A and B Vaccination Sales Market Share by Application (2017-2028)
  • 5.2 Global Hepatitis A and B Vaccination Revenue by Application
    • 5.2.1 Global Hepatitis A and B Vaccination Historical Revenue by Application (2017-2022)
    • 5.2.2 Global Hepatitis A and B Vaccination Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Global Hepatitis A and B Vaccination Revenue Market Share by Application (2017-2028)
  • 5.3 Global Hepatitis A and B Vaccination Price by Application
    • 5.3.1 Global Hepatitis A and B Vaccination Price by Application (2017-2022)
    • 5.3.2 Global Hepatitis A and B Vaccination Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Hepatitis A and B Vaccination Market Size by Type
    • 6.1.1 North America Hepatitis A and B Vaccination Sales by Type (2017-2028)
    • 6.1.2 North America Hepatitis A and B Vaccination Revenue by Type (2017-2028)
  • 6.2 North America Hepatitis A and B Vaccination Market Size by Application
    • 6.2.1 North America Hepatitis A and B Vaccination Sales by Application (2017-2028)
    • 6.2.2 North America Hepatitis A and B Vaccination Revenue by Application (2017-2028)
  • 6.3 North America Hepatitis A and B Vaccination Market Size by Country
    • 6.3.1 North America Hepatitis A and B Vaccination Sales by Country (2017-2028)
    • 6.3.2 North America Hepatitis A and B Vaccination Revenue by Country (2017-2028)
    • 6.3.3 United States
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Hepatitis A and B Vaccination Market Size by Type
    • 7.1.1 Europe Hepatitis A and B Vaccination Sales by Type (2017-2028)
    • 7.1.2 Europe Hepatitis A and B Vaccination Revenue by Type (2017-2028)
  • 7.2 Europe Hepatitis A and B Vaccination Market Size by Application
    • 7.2.1 Europe Hepatitis A and B Vaccination Sales by Application (2017-2028)
    • 7.2.2 Europe Hepatitis A and B Vaccination Revenue by Application (2017-2028)
  • 7.3 Europe Hepatitis A and B Vaccination Market Size by Country
    • 7.3.1 Europe Hepatitis A and B Vaccination Sales by Country (2017-2028)
    • 7.3.2 Europe Hepatitis A and B Vaccination Revenue by Country (2017-2028)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Hepatitis A and B Vaccination Market Size by Type
    • 8.1.1 Asia Pacific Hepatitis A and B Vaccination Sales by Type (2017-2028)
    • 8.1.2 Asia Pacific Hepatitis A and B Vaccination Revenue by Type (2017-2028)
  • 8.2 Asia Pacific Hepatitis A and B Vaccination Market Size by Application
    • 8.2.1 Asia Pacific Hepatitis A and B Vaccination Sales by Application (2017-2028)
    • 8.2.2 Asia Pacific Hepatitis A and B Vaccination Revenue by Application (2017-2028)
  • 8.3 Asia Pacific Hepatitis A and B Vaccination Market Size by Region
    • 8.3.1 Asia Pacific Hepatitis A and B Vaccination Sales by Region (2017-2028)
    • 8.3.2 Asia Pacific Hepatitis A and B Vaccination Revenue by Region (2017-2028)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 China Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia

9 Latin America

  • 9.1 Latin America Hepatitis A and B Vaccination Market Size by Type
    • 9.1.1 Latin America Hepatitis A and B Vaccination Sales by Type (2017-2028)
    • 9.1.2 Latin America Hepatitis A and B Vaccination Revenue by Type (2017-2028)
  • 9.2 Latin America Hepatitis A and B Vaccination Market Size by Application
    • 9.2.1 Latin America Hepatitis A and B Vaccination Sales by Application (2017-2028)
    • 9.2.2 Latin America Hepatitis A and B Vaccination Revenue by Application (2017-2028)
  • 9.3 Latin America Hepatitis A and B Vaccination Market Size by Country
    • 9.3.1 Latin America Hepatitis A and B Vaccination Sales by Country (2017-2028)
    • 9.3.2 Latin America Hepatitis A and B Vaccination Revenue by Country (2017-2028)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Hepatitis A and B Vaccination Market Size by Type
    • 10.1.1 Middle East and Africa Hepatitis A and B Vaccination Sales by Type (2017-2028)
    • 10.1.2 Middle East and Africa Hepatitis A and B Vaccination Revenue by Type (2017-2028)
  • 10.2 Middle East and Africa Hepatitis A and B Vaccination Market Size by Application
    • 10.2.1 Middle East and Africa Hepatitis A and B Vaccination Sales by Application (2017-2028)
    • 10.2.2 Middle East and Africa Hepatitis A and B Vaccination Revenue by Application (2017-2028)
  • 10.3 Middle East and Africa Hepatitis A and B Vaccination Market Size by Country
    • 10.3.1 Middle East and Africa Hepatitis A and B Vaccination Sales by Country (2017-2028)
    • 10.3.2 Middle East and Africa Hepatitis A and B Vaccination Revenue by Country (2017-2028)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 GSK
    • 11.1.1 GSK Corporation Information
    • 11.1.2 GSK Overview
    • 11.1.3 GSK Hepatitis A and B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.1.4 GSK Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 GSK Recent Developments
  • 11.2 Merck
    • 11.2.1 Merck Corporation Information
    • 11.2.2 Merck Overview
    • 11.2.3 Merck Hepatitis A and B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.2.4 Merck Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Merck Recent Developments
  • 11.3 Sanofi
    • 11.3.1 Sanofi Corporation Information
    • 11.3.2 Sanofi Overview
    • 11.3.3 Sanofi Hepatitis A and B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.3.4 Sanofi Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Sanofi Recent Developments
  • 11.4 Sinovac
    • 11.4.1 Sinovac Corporation Information
    • 11.4.2 Sinovac Overview
    • 11.4.3 Sinovac Hepatitis A and B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.4.4 Sinovac Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Sinovac Recent Developments
  • 11.5 Zhejiang Pukang
    • 11.5.1 Zhejiang Pukang Corporation Information
    • 11.5.2 Zhejiang Pukang Overview
    • 11.5.3 Zhejiang Pukang Hepatitis A and B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.5.4 Zhejiang Pukang Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Zhejiang Pukang Recent Developments
  • 11.6 Changchun Institute of Biological
    • 11.6.1 Changchun Institute of Biological Corporation Information
    • 11.6.2 Changchun Institute of Biological Overview
    • 11.6.3 Changchun Institute of Biological Hepatitis A and B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.6.4 Changchun Institute of Biological Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Changchun Institute of Biological Recent Developments
  • 11.7 KM Biologics
    • 11.7.1 KM Biologics Corporation Information
    • 11.7.2 KM Biologics Overview
    • 11.7.3 KM Biologics Hepatitis A and B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.7.4 KM Biologics Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 KM Biologics Recent Developments
  • 11.8 IMBCAMS
    • 11.8.1 IMBCAMS Corporation Information
    • 11.8.2 IMBCAMS Overview
    • 11.8.3 IMBCAMS Hepatitis A and B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.8.4 IMBCAMS Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 IMBCAMS Recent Developments
  • 11.9 Convac
    • 11.9.1 Convac Corporation Information
    • 11.9.2 Convac Overview
    • 11.9.3 Convac Hepatitis A and B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.9.4 Convac Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Convac Recent Developments
  • 11.10 NCPC
    • 11.10.1 NCPC Corporation Information
    • 11.10.2 NCPC Overview
    • 11.10.3 NCPC Hepatitis A and B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.10.4 NCPC Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 NCPC Recent Developments
  • 11.11 Bio Kangtai
    • 11.11.1 Bio Kangtai Corporation Information
    • 11.11.2 Bio Kangtai Overview
    • 11.11.3 Bio Kangtai Hepatitis A and B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.11.4 Bio Kangtai Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 Bio Kangtai Recent Developments
  • 11.12 Dynavax
    • 11.12.1 Dynavax Corporation Information
    • 11.12.2 Dynavax Overview
    • 11.12.3 Dynavax Hepatitis A and B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.12.4 Dynavax Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Dynavax Recent Developments
  • 11.13 Hissen
    • 11.13.1 Hissen Corporation Information
    • 11.13.2 Hissen Overview
    • 11.13.3 Hissen Hepatitis A and B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.13.4 Hissen Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.13.5 Hissen Recent Developments
  • 11.14 LG Life Sciences
    • 11.14.1 LG Life Sciences Corporation Information
    • 11.14.2 LG Life Sciences Overview
    • 11.14.3 LG Life Sciences Hepatitis A and B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.14.4 LG Life Sciences Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.14.5 LG Life Sciences Recent Developments
  • 11.15 Serum Institute
    • 11.15.1 Serum Institute Corporation Information
    • 11.15.2 Serum Institute Overview
    • 11.15.3 Serum Institute Hepatitis A and B Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.15.4 Serum Institute Hepatitis A and B Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.15.5 Serum Institute Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Hepatitis A and B Vaccination Industry Chain Analysis
  • 12.2 Hepatitis A and B Vaccination Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Hepatitis A and B Vaccination Production Mode & Process
  • 12.4 Hepatitis A and B Vaccination Sales and Marketing
    • 12.4.1 Hepatitis A and B Vaccination Sales Channels
    • 12.4.2 Hepatitis A and B Vaccination Distributors
  • 12.5 Hepatitis A and B Vaccination Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Hepatitis A and B Vaccination Industry Trends
  • 13.2 Hepatitis A and B Vaccination Market Drivers
  • 13.3 Hepatitis A and B Vaccination Market Challenges
  • 13.4 Hepatitis A and B Vaccination Market Restraints

14 Key Findings in The Global Hepatitis A and B Vaccination Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer